- Home
- DVS vs OPRX Comparison
DVS vs OPRX Comparison
Compare DVS & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVS
- OPRX
- Stock Information
- Founded
- DVS 2011
- OPRX 2006
- Country
- DVS Canada
- OPRX United States
- Employees
- DVS N/A
- OPRX N/A
- Industry
- DVS
- OPRX Business Services
- Sector
- DVS
- OPRX Consumer Discretionary
- Exchange
- DVS Nasdaq
- OPRX Nasdaq
- Market Cap
- DVS 362.6M
- OPRX 380.6M
- IPO Year
- DVS N/A
- OPRX N/A
- Fundamental
- Price
- DVS $4.74
- OPRX $17.68
- Analyst Decision
- DVS
- OPRX Buy
- Analyst Count
- DVS 0
- OPRX 8
- Target Price
- DVS N/A
- OPRX $11.81
- AVG Volume (30 Days)
- DVS 863.4K
- OPRX 374.6K
- Earning Date
- DVS 11-23-2025
- OPRX 11-12-2025
- Dividend Yield
- DVS N/A
- OPRX N/A
- EPS Growth
- DVS N/A
- OPRX N/A
- EPS
- DVS N/A
- OPRX N/A
- Revenue
- DVS N/A
- OPRX $104,748,000.00
- Revenue This Year
- DVS N/A
- OPRX $17.92
- Revenue Next Year
- DVS N/A
- OPRX $10.91
- P/E Ratio
- DVS N/A
- OPRX N/A
- Revenue Growth
- DVS N/A
- OPRX 25.89
- 52 Week Low
- DVS $2.48
- OPRX $3.78
- 52 Week High
- DVS $5.38
- OPRX $20.70
- Technical
- Relative Strength Index (RSI)
- DVS 57.75
- OPRX 47.74
- Support Level
- DVS $4.68
- OPRX $17.24
- Resistance Level
- DVS $5.38
- OPRX $20.70
- Average True Range (ATR)
- DVS 0.30
- OPRX 1.19
- MACD
- DVS 0.00
- OPRX -0.20
- Stochastic Oscillator
- DVS 53.28
- OPRX 12.72
About DVS Dolly Varden Silver Corporation Common Shares
Dolly Varden Silver Corp is a mineral exploration company. The company's primary business is the acquisition, exploration, evaluation, and development of exploration and evaluation assets. It is focused on exploration advancing the Kitsault Valley Project, which includes the Dolly Varden property and the Homestake Ridge property located in the Golden Triangle of British Columbia, Canada.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.